Whole exome sequencing identifies clinically relevant mutational signatures in resected hepatocellular carcinoma
Liver Cancer International · 2020
DOI: 10.1002/lci2.14 ↗Kurz gefasst
Fachartikel in der Zeitschrift Liver Cancer International, 2020. Verfasst von Jason Y. Chan und 24 weiteren Autor:innen. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Singapore Ministry of Health's National Medical Research Council Singapore Translational Research Investigator Award:, Singapore Ministry of Health's National Medical Research Council Clinician-Scientist Individual Research Grants, Singapore Ministry of Health's National Medical Research Council Research Training Fellowship.
Abstract (Originalsprache)
Background & Aims Most patients develop recurrent disease despite curative surgery for hepatocellular carcinoma (HCC). No standard adjuvant therapy is available and molecular predictors of outcome are poorly understood.
Methods
We conducted a multicentre pilot study on patients with localized HCC following surgical resection. Patients received up to 6 months of oral gefitinib as adjuvant therapy. Clinical end points included recurrence‐free survival (RFS) and overall survival (OS), and exploratory analyses were conducted from whole exome sequencing data.
Results
A total of 65 patients were screened for the study, of which 40 were eligible. The median age was 63 years (range, 44‐80). Most patients (80%) were positive for hepatitis B or C. With a median follow‐up of 4.5 years, the median RFS was 24 months. Median OS was not reached. High Child‐Pugh score and advanced T‐stage (3‐4) were independent predictors for both OS and RFS. Mutational signatures for exposure to aristolochic acid (AA), as characterized by a majority of T:A > A:T mutations, were observed in 18 cases (55%). HCC without AA mutagenesis was associated with early recurrences or death within 2 years of surgery ( P = .037). HCC with high T > A mutations was associated with better OS (HR 0.29, 95% CI 0.09‐0.90, P = .033). Conversely, HCC with high C > T mutations was associated with worse OS (HR 4.55, 95% CI 1.20‐17.31, P = .026).
Conclusions
Mutational signatures may carry prognostic significance in HCC following curative resection. Patient outcomes with gefitinib as adjuvant therapy after resection for HCC were modest, highlighting the need for urgent research in this area of unmet clinical need. ClinicalTrials.gov number, NCT00282100.
Förderung
- Singapore Ministry of Health's National Medical Research Council Singapore Translational Research Investigator Award:
- Singapore Ministry of Health's National Medical Research Council Clinician-Scientist Individual Research Grants
- Singapore Ministry of Health's National Medical Research Council Research Training Fellowship
- SingHealth Duke-NUS Academic Medical Centre and Oncology ACP Nurturing Clinician Scientist Scheme
- SHF-Foundation Research
- Singapore Cancer Syndicate, Johns Hopkins Singapore Research
Zitieren
APA
Chan, J. Y., Lim, A. H., Boot, A., Lee, E., Ng, C. C., Lee, J. Y., Rajasegaran, V., Liu, W., Goh, S., Hong, J. H., Xu, X., Bharwani, L. D., Chan, C. Y., Chung, A. Y. F., Cheow, P. C., Tan, C., Ho, C. K., Liau, K. H., Woon, W. W. L., …, & Chang, A. Y. (2020). Whole exome sequencing identifies clinically relevant mutational signatures in resected hepatocellular carcinoma. Liver Cancer International. https://doi.org/10.1002/lci2.14
Vancouver
Chan JY, Lim AH, Boot A, Lee E, Ng CC, Lee JY, et al. Whole exome sequencing identifies clinically relevant mutational signatures in resected hepatocellular carcinoma. Liver Cancer International. 2020. doi:10.1002/lci2.14
BibTeX
@article{Chan2020,
author = {Chan, Jason Y. and Lim, Abner H. and Boot, Arnoud and Lee, Elizabeth and Ng, Cedric C.‐Y. and Lee, Jing Y. and Rajasegaran, Vikneswari and Liu, Wei and Goh, Shane and Hong, Jing H. and Xu, Xiaoying and Bharwani, Lavina D. and Chan, Chung Y. and Chung, Alexander Y. F. and Cheow, Peng C. and Tan, Chee‐Kiat and Ho, Choon K. and Liau, Kui H. and Woon, Winston W. L. and Low, Jee K. and Chopra, Akhil and Lopes, Gilberto and Rozen, Steven G. and Teh, Bin T. and Chang, Alex Y.‐C.},
title = {Whole exome sequencing identifies clinically relevant mutational signatures in resected hepatocellular carcinoma},
journal = {Liver Cancer International},
year = {2020},
doi = {10.1002/lci2.14}
}
EUVIMED